Holen Sie sich die Stockscreener-App
16.49
1.79%
-0.30
Schlusskurs vom Vortag:
$16.79
Offen:
$16.91
24-Stunden-Volumen:
1.09M
Relative Volume:
0.75
Marktkapitalisierung:
$1.23B
Einnahmen:
$254.91M
Nettoeinkommen (Verlust:
$-103.48M
KGV:
-11.75
EPS:
-1.4036
Netto-Cashflow:
$-148.35M
1W Leistung:
-2.31%
1M Leistung:
+16.54%
6M Leistung:
-10.33%
1J Leistung:
-24.04%
1-Tages-Spanne:
$15.93
$16.91
1-Wochen-Bereich:
$15.74
$17.47
52-Wochen-Spanne:
$10.95
$23.75
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
16.49 | 1.23B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
190.12 | 30.88B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
71.43 | 14.02B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.23 | 10.46B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.40 | 7.89B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.80 | 6.87B | 646.34M | -512.40M | 202.76M | -6.6871 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development - GlobeNewswire Inc.
Price to sales forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
(SDGR) Volatility Zones as Tactical Triggers - Stock Traders Daily
Schrodinger Inc. (SDGR) Jumps 3.73% as Software-Driven Drug Discovery Gains TractionGap and Reverse - dars.gov.et
Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR) - Seeking Alpha
Schrodinger explores computational chemistry. Nasdaq biotech stock leans on its platform - AD HOC NEWS
Citigroup Downgrades Schrödinger (SDGR) - MSN
SDGRSchrodinger Inc Latest SEC Filings - Finviz
Jain Rachit, Schrodinger CFO, sells $21k in SDGR stock By Investing.com - Investing.com Nigeria
Form 144 Schrodinger For: 1 July By Investing.com - Investing.com India
Enterprise value to EBIT forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
A Look at Schrodinger Inc (SDGR) After 6.6% Decline -- GF Value $26.32 vs Price $16.25 - GuruFocus
Schrodinger, Inc. Receives $57 Million from Eli Lilly’s Acquisition of Ajax Therapeutics – Key Financial Update - Minichart
Form 4 Schrodinger Inc For: 29 June By Investing.com - Investing.com South Africa
Schrodinger receives ~$57M cash payment after Eli Lilly acquisition of Ajax - TradingView
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength? - Yahoo Finance
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Schrodinger Inc (SDGR) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Schrodinger, Inc. Actuals & Estimates (SWB:43Z) - TradingView
Schrodinger, Inc. Actuals & Estimates (NASDAQ:SDGR) - TradingView
Schrodinger, Inc. Actuals & Estimates (DUS:43Z) - TradingView
SDGR Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Schrodinger Inc For: 23 June By Investing.com - Investing.com Nigeria
Schrodinger (SDGR) director receives 8,141 RSUs and 13,313 stock options - Stock Titan
Schrödinger Shareholders Expand Equity Plan, Elect Directors - TipRanks
Director Jeffrey Chodakewitz receives RSUs and options at Schrodinger (SDGR) - Stock Titan
Schrodinger (NASDAQ: SDGR) director receives RSU and stock option grants - Stock Titan
Schrodinger (NASDAQ: SDGR) director receives RSUs and stock option grant - Stock Titan
Schrodinger | 4: Statement of changes in beneficial ownership of securities-Director GINSBERG GARY L - Moomoo
Schrödinger (NASDAQ: SDGR) director receives new RSU and stock option awards - Stock Titan
Schrodinger (SDGR) grants RSUs and stock options to director Nancy Thornberry - Stock Titan
Schrodinger, Inc. (SDGR) director granted RSUs and stock options - Stock Titan
Shareholders back Schrodinger (NASDAQ: SDGR) equity plan, director slate and KPMG - Stock Titan
Morgan Stanley Maintains an Equal Weight” rating on Schrödinger, Inc. (SDGR) - Insider Monkey
SDGR: All proposals passed and strategic focus remains on AI-driven molecular discovery innovation - TradingView
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On - Insider Monkey
Schrodinger Inc 2026 Outlook Suggests Platform-Driven Growth TrajectoryPerformance Review - dars.gov.et
Schrodinger Inc (SDGR) 2026 Outlook: Key Signals for the Drug Discovery PlatformAnalyst Coverage Count - Město Břeclav
What Does Schrodinger Inc (SDGR)’s 2026 Outlook Reveal? - Insider Monkey
Schrodinger Inc (SDGR) Eyes 2026: Software Growth and Pipeline Milestones in FocusCFO Commentary Report - dars.gov.et
Schrodinger (SDGR) Issues Restricted Stock Units to New Employees - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
(SDGR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Schrodinger Inc (SDGR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Schrodinger Inc (SDGR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Schrodinger Inc (SDGR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Schrodinger Inc (SDGR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Schrodinger Inc (SDGR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):